QT
YMAB

Quantbot Technologies’s Y-mAbs Therapeutics YMAB Stock Holding History

Quantbot Technologies’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,532
Closed -$73.7K – 1974
2024
Q1 		$73.7K Buy
+4,532
New +$61.1K ﹤0.01% 1267
2023
Q3 		– Sell
-900
Closed -$6.11K – 2031
2023
Q2 		$6.11K Buy
+900
New +$6.75K ﹤0.01% 1487
2022
Q1 		– Sell
-2,700
Closed -$43K – 2112
2021
Q4 		$43K Buy
2,700
+2,100
+350% +$44.9K ﹤0.01% 1064
2021
Q3 		$17K Buy
+600
New +$18.9K ﹤0.01% 1298
2021
Q1 		– Sell
-200
Closed -$9K – 1810
2020
Q4 		$9K Buy
+200
New +$9.25K ﹤0.01% 1112

Other funds holding YMAB

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Quantbot Technologies's YMAB Position: Q2 2024 in Review

Quantbot Technologies sold out of Y-mAbs Therapeutics (YMAB) in Q2 2024, closing a stake of 4,532 shares — an estimated $73.7K sold.

Quantbot Technologies first reported a position in YMAB in Q4 2020 and held it in 5 quarters. The position peaked at $73.7K in Q1 2024. 96 funds tracked by Wall St. Rank hold YMAB as of Q2 2024.

  • Quantbot Technologies reported no remaining Y-mAbs Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 4,532 Y-mAbs Therapeutics shares in Q2 2024, an estimated $73.7K.
  • Quantbot Technologies first reported a position in Y-mAbs Therapeutics in Q4 2020 and held it in 5 quarters.
  • Quantbot Technologies's Y-mAbs Therapeutics position peaked at $73.7K in Q1 2024.
  • 96 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.